• Text size
  • Send this article to a friend
  • Print this article

Ardana in new blow to life sciences

Ardana, the small-cap pharmaceutical company, yesterday put itself up for sale amid a potentially crippling cash crunch, marking what could be the second blow to the Scottish life science sector in less than a week.

Ardana, the small-cap pharmaceutical company, yesterday put itself up for sale amid a potentially crippling cash crunch, marking what could be the second blow to the Scottish life science sector in less than a week.